Group 1 - The core issue involves a shareholder named Xiao filing a claim against Tianpu Co., with the legal representation accepted by lawyer Chen Yuxia [1] - The Sina shareholder rights protection platform currently has 13 professional lawyers available to represent claims against Tianpu Co., with a total of 13 claims received [2] - The conditions for compensation include purchasing shares between the company's listing and December 31, 2025, and selling or holding them as of January 1, 2026 [3] Group 2 - The platform provides multiple entry points for filing claims, including following Sina Securities on Weibo and WeChat, and accessing the Sina Finance app [3] - Important notes for filling out the claim form include providing detailed personal information and ensuring the uploaded account statement is clear and legally valid [4] - The claim process requires the submission of a stock account statement that includes key information such as stock details, transaction dates, and quantities [4][7]

Group 1 - The core viewpoint of the news is that a shareholder named Huang has submitted a claim against Pairui Co., Ltd. through the Sina shareholder rights protection platform, which has accepted the case and will monitor the compensation process [1] - The Sina shareholder rights protection platform currently has 13 professional lawyers available to represent claims against Pairui Co., Ltd., and has received a total of 40 claims related to the company [2] Group 2 - The conditions for compensation from Pairui Co., Ltd. include purchasing shares between the company's listing and December 26, 2025, and either selling or still holding the shares by the close on December 27, 2025 [3] - The platform provides multiple entry points for shareholders to initiate claims, including following Sina Securities on Weibo, Sina's brokerage fund on WeChat, and visiting the Sina Finance app or homepage [3] - Important notes for filling out the claim form include providing detailed personal information, ensuring the uploaded account statement is clear and legally valid, and including key information such as stock details, transaction dates, and quantities [4]

Core Viewpoint - Shandong Xinhua Jin International Co., Ltd. (referred to as "Xinhua Jin" or "the company") has experienced abnormal stock trading fluctuations, with a cumulative price deviation exceeding 12% from January 5 to January 7, 2026, triggering regulatory scrutiny and potential investor claims [1][3]. Group 1: Stock Trading and Regulatory Actions - Xinhua Jin's stock price deviation triggered an abnormal trading situation as per the Shanghai Stock Exchange rules [1][3]. - The company is facing investor claims due to administrative regulatory measures issued against it [2][4]. - The company reported that the actual amount of related party transactions in 2023 was significantly lower than expected, while the scale of related guarantees increased substantially [1][3]. Group 2: Investor Claims and Conditions - Investors who purchased shares between March 30, 2019, and April 29, 2024, and still hold them, are eligible to voluntarily register for claims, regardless of whether they sell after April 30, 2024 [3][5]. - The company disclosed that related party transactions involved various business activities, including sales, procurement, and leasing [1][3]. - A significant non-operating fund occupation of 406 million yuan by Xinhua Jin Group and its related parties was revealed in the 2025 semi-annual report, leading to regulatory measures from the Qingdao Securities Regulatory Bureau [1][3].

Group 1 - The core viewpoint of the news is that a shareholder named Zhang has submitted a claim against Pairui Co., and the claim has been accepted by lawyer Zhang Haifeng. The Sina shareholder rights protection platform will monitor the compensation process for this shareholder [1] - The platform currently has 13 professional lawyers available to represent claims against Pairui Co., and has received a total of 18 claims related to the company [1] Group 2 - The conditions for compensation include purchasing shares between the company's listing and December 26, 2025, and either selling or still holding the shares by the close of December 27, 2025 [2] - Multiple entry points for quick rights protection are available, including following Sina Securities on Weibo, Sina Fund on WeChat, and visiting the Sina Finance app or homepage [2] Group 3 - Important notes for filling out the rights protection form include providing detailed personal information, ensuring the uploaded account statement is clear and identifiable, and that it must include stock information, transaction time, and quantity [3] - The account statement must be a legally valid document issued by a securities company in JPG format or electronic form; handwritten statements are invalid [3] Group 4 - The first step in the complaint process involves filling out basic information such as name, contact details, and estimated loss amount [4] - The second step requires detailing the complaint reason and uploading relevant materials, including a clear stock account statement [5][6]

Core Viewpoint - Zhuojin Co., Ltd. (688701) has been penalized by the China Securities Regulatory Commission for failing to disclose important information in its prospectus and periodic reports, leading to potential claims from affected investors [1][2]. Summary by Relevant Sections Company Information - Zhuojin Co., Ltd. has been subject to administrative penalties due to non-compliance with disclosure regulations [1][2]. Investor Claims - Affected investors who purchased Zhuojin shares between February 25, 2022, and October 31, 2022, and held or sold their shares by the end of October 31, 2022, are eligible to file claims [1][2]. - The deadline for filing claims is February 3, 2026, urging eligible investors to complete the registration and legal procedures before this date to avoid losing their right to sue [3]. Required Documentation for Claims - Investors must provide the following documents to support their claims: 1. Original transaction statements for Zhuojin shares, stamped by the brokerage [4]. 2. Copies of the investor's ID (front and back) [4]. 3. A securities account inquiry statement issued by the brokerage [4].

Group 1 - The core viewpoint of the news is that a shareholder named Hou has submitted a claim against Haide Co., and the claim has been accepted by lawyer Song Yixin. The Sina shareholder rights protection platform is monitoring the compensation process and is continuing to collect related claims [1] - The Sina shareholder rights protection platform currently has 13 professional lawyers available to represent claims against Haide Co., and has received a total of 6 claims related to the company [1] Group 2 - The conditions for claiming compensation from Haide Co. include purchasing shares between the company's listing and April 28, 2025, and either selling or still holding the shares by the close of trading on April 29, 2025 [2] - Multiple lawyers are available to accept claims, including Liu Peng, Chen Yuxia, Xu Feng, Song Yixin, and others [2] - The platform provides various entry points for quick claims, including following Sina Securities on Weibo, WeChat, and accessing the Sina Finance app [2] Group 3 - Important notes for filling out the claim form include providing detailed personal information and ensuring that the uploaded account statement is clear and recognizable [3] - The account statement must include stock information, transaction dates, and quantities, and must be in a legally valid format from a securities company [3] Group 4 - The first step in the claims process involves filling out basic information such as name, contact details, and estimated loss amount [4] - The second step requires detailing the complaint reason and uploading relevant materials, including a stock account statement [5][6]

Core Viewpoint - The rapid decline of Nohui Health, once a leading company in cancer early screening, is attributed to allegations of financial fraud, leading to its forced delisting from the Hong Kong Stock Exchange within a span of just over two years [1][21][24]. Company Overview - Nohui Health was accused by CapitalWatch in August 2023 of inflating its revenue by nearly 90%, which led to a halt in trading after Deloitte refused to sign off on the company's annual report due to unverifiable financial data [1][21]. - The company was officially delisted on October 27, 2025, after failing to meet the Hong Kong Stock Exchange's resumption guidelines [1][24]. Operational Status - The headquarters in Hangzhou is largely abandoned, with multiple locked doors and a significant decrease in sample reception volume, indicating a decline in operational activity [3][4][6]. - The main operational site, located in the Hehui Technology Park, has seen its office space largely vacated, with only a small portion still in use [4][6][12]. Financial Performance - Nohui Health's financial troubles were highlighted by a significant discrepancy between reported sales and actual performance, with a claimed revenue of 765 million yuan in 2022 versus an estimated actual sales figure of only 76.95 million yuan [21]. - The company's promotional activities have diminished, with drastic price variations observed across different e-commerce platforms, raising concerns about potential inventory liquidation [20][22]. Legal and Regulatory Challenges - The company is facing a complex legal landscape as it seeks to navigate potential liquidation proceedings, with over 4,000 individual investors forming a coalition to pursue claims against the company [23][24][26]. - Legal experts indicate that the challenges for investors include establishing a clear evidence chain of financial misconduct and navigating the complexities of cross-border legal frameworks due to the company's registration in the Cayman Islands and listing in Hong Kong [26][27].

Core Viewpoint - The rapid decline of Nohui Health, once a leading player in cancer early screening, is attributed to allegations of financial fraud, leading to its forced delisting from the Hong Kong Stock Exchange within two years [2][21][24]. Company Overview - Nohui Health was established in 2013 and became a prominent company in cancer screening technology, with its headquarters located in Hangzhou, China [4][21]. - The company faced severe operational challenges, including a significant drop in sample reception and a lack of personnel at its facilities [3][8][12]. Financial Allegations - A short-selling report by CapitalWatch in August 2023 accused Nohui Health of inflating its revenue by nearly 90%, claiming that the actual sales for 2022 were only 76.95 million yuan, compared to the reported 765 million yuan [21][24]. - The company’s stock was suspended in March 2024 due to Deloitte's refusal to sign off on its financial statements, leading to its eventual delisting in October 2025 [2][21]. Operational Status - The main office in Hangzhou is now largely abandoned, with only a small portion still operational, indicating a drastic reduction in business activity [6][12]. - The laboratory facilities, including the sample reception area, show signs of inactivity, with no personnel present during visits [8][11]. Legal and Regulatory Challenges - Nohui Health is facing a complex legal situation, including potential liquidation proceedings in the Cayman Islands, which could severely impact individual investors [24][27]. - Over 4,000 individual investors have formed a collective to seek compensation for their losses, with claims exceeding 700 million Hong Kong dollars [24][28]. Product and Market Dynamics - The company’s flagship product, Changweiqing, is facing challenges as its medical device registration certificate is set to expire, raising concerns about its market viability [22][23]. - Despite previous sales successes during promotional events like "Double 11," the current promotional strategies and pricing appear disorganized, leading to potential market confusion [22][23].

Group 1 - The core viewpoint of the news is that a shareholder named Xu has submitted a claim for compensation against ST Pava, and the claim has been accepted by lawyer Xu Jin. The Sina shareholder rights protection platform is monitoring the compensation process and is continuing to gather related claims [1] - The Sina shareholder rights protection platform currently has 13 professional lawyers available to represent claims against ST Pava, and has received a total of 44 claims related to this company [1] Group 2 - Compensation conditions for ST Pava include purchasing shares between September 19, 2022, and March 25, 2025, and selling or still holding them by the close on March 26, 2025 [2] - Multiple lawyers are available to accept claims, including Liu Yanmei, Liu Peng, Song Yixin, Li Jian, Xu Jin, Zhao Jingguo, Xu Feng, Liu Binghua, Li Hongjie, Zhang Haifeng, and Niu Bin [2] - The platform provides various entry points for quick claims, including following Sina Securities on Weibo, WeChat, and accessing the Sina Finance app [2] Group 3 - Important notes for filling out the claim form include providing detailed personal information, ensuring the uploaded account statement is clear and recognizable, and including key information such as stock details, transaction dates, and quantities [3] - The account statement must be a legally valid document issued by a securities company in JPG format or electronic format; handwritten statements are invalid [3] Group 4 - The first step in the claims process involves filling out basic information such as name, contact information, and estimated loss amount [4] - The second step requires detailing the reason for the complaint and uploading relevant materials, including a stock account statement [5][6]

Group 1 - The core viewpoint of the news is that a shareholder named Yuan has submitted a claim for compensation against Zhitian Tui, and the claim has been accepted by lawyer Liu Peng. The Sina shareholder rights protection platform is monitoring the compensation process and continues to collect related claims [1] - The Sina shareholder rights protection platform currently has 12 professional lawyers available to represent claims against Zhitian Tui, and has received a total of 113 claims related to this company [1] Group 2 - Compensation conditions for Zhitian Tui include purchasing shares between April 28, 2023, and October 27, 2024, and selling or holding them by the close on October 28, 2024. Lawyers accepting these claims include Liu Peng and others [2] - There are multiple entry points for quick rights protection, including following Sina Securities on Weibo, WeChat, and visiting the Sina Finance app or homepage. Investors need to fill out personal information, select the company and reason for compensation, and upload stock statements [2] Group 3 - Important notes for filling out the compensation form include providing detailed personal information, ensuring the uploaded stock statement is clear and identifiable, and that it contains key information such as stock details, transaction dates, and quantities. The statement must be in JPG format or electronic form from a securities company [3]